Published in Eur J Gastroenterol Hepatol on May 01, 2003
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology (2009) 3.31
Nonalcoholic fatty liver disease. CMAJ (2005) 2.56
Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology (2011) 2.42
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2010) 2.28
Treatment of non-alcoholic fatty liver disease. Postgrad Med J (2006) 1.63
Non-invasive means of measuring hepatic fat content. World J Gastroenterol (2008) 1.60
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol (2008) 1.43
Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol (2009) 1.23
Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab (2012) 1.20
The functional pitch of an organ: quantification of tissue texture with photoacoustic spectrum analysis. Radiology (2014) 1.15
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) (2007) 1.13
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12
A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol (2012) 1.09
Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch (2011) 1.07
Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver (2010) 1.03
The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol (2005) 0.99
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol (2013) 0.98
Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? Cardiovasc Diabetol (2012) 0.93
[Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines]. Pathologe (2010) 0.90
Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. Iran Red Crescent Med J (2014) 0.88
Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. J Gastroenterol (2012) 0.86
Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. Endocrinol Metab (Seoul) (2013) 0.85
Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults. World J Gastroenterol (2007) 0.85
Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care (2008) 0.84
The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab (2012) 0.84
Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China. Int J Mol Sci (2013) 0.83
The Risk of Abdominal Obesity according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men. J Korean Med Sci (2016) 0.83
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study. World J Gastroenterol (2014) 0.81
Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile. Fertil Steril (2013) 0.81
Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. J Lipid Res (2011) 0.81
Simultaneous assessment of liver volume and whole liver fat content: a step towards one-stop shop preoperative MRI protocol. Eur Radiol (2010) 0.80
Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study. Endocrinol Metab (Seoul) (2015) 0.80
Detecting hepatic steatosis using ultrasound-induced thermal strain imaging: an ex vivo animal study. Phys Med Biol (2014) 0.80
Clinical significance of non-alcoholic fatty liver disease as a risk factor for prehypertension. J Korean Med Sci (2014) 0.80
Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. J Spinal Cord Med (2016) 0.80
Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels. Metabolism (2013) 0.79
Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open (2014) 0.79
Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol (2011) 0.79
Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. J Nutr Metab (2013) 0.78
Current status of therapy in nonalcoholic Fatty liver disease. Therap Adv Gastroenterol (2009) 0.78
Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study. J Gastroenterol (2014) 0.78
Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman. Gastroenterol Hepatol Bed Bench (2012) 0.77
Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol (2016) 0.77
The Risk for Insulin Resistance according to the Degree of Non-Alcoholic Fatty Liver Disease in Korean Men. J Korean Med Sci (2016) 0.77
Clinical problem solving: utility of sonography in oncologic patients. J Ultrasound Med (2014) 0.76
The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis. J Ultrasound (2014) 0.75
Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study. PLoS One (2016) 0.75
Probable NAFLD, by ALT levels, and diabetes among Filipino-American women. Diabetes Res Clin Pract (2007) 0.75
Correlation between liver fat content with dyslipidemia and Insulin resistance. Indian J Endocrinol Metab (2013) 0.75
Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients. Int J Endocrinol (2017) 0.75
Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population. J Korean Med Sci (2017) 0.75
Biermer's anemia: a new cause of cholestasis and hepatic steatosis? Dig Dis Sci (2007) 0.75
Guidelines for the management of iron deficiency anaemia. Gut (2011) 2.28
Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia. Eur J Gastroenterol Hepatol (2005) 0.94
Should patients with coeliac disease have their bone mineral density measured? Eur J Gastroenterol Hepatol (2005) 0.90
Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol (2007) 0.87
The prevalence of coeliac disease in rheumatoid arthritis. Eur J Gastroenterol Hepatol (2002) 0.81
Comparison between Tc-HMPAO labelled white cells and Tc LeukoScan in the investigation of inflammatory bowel disease. Nucl Med Commun (2005) 0.77
Head-at-risk signs in Legg-Calvé-Perthes disease: poor inter- and intra-observer reliability. Acta Orthop (2006) 0.77
Delayed healing of percutaneous endoscopic gastrostomy site during chemotherapy. Gut (2007) 0.75